Molina Healthcare (MOH)
(Delayed Data from NYSE)
$306.00 USD
-3.30 (-1.07%)
Updated Nov 14, 2024 04:00 PM ET
Pre-Market: $308.00 +2.00 (0.65%) 9:04 AM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$306.00 USD
-3.30 (-1.07%)
Updated Nov 14, 2024 04:00 PM ET
Pre-Market: $308.00 +2.00 (0.65%) 9:04 AM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Zacks News
Top Ranked Growth Stocks to Buy for July 30th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 30th.
Is a Beat in Store for Molina Healthcare (MOH) Q2 Earnings?
by Zacks Equity Research
Molina Healthcare's (MOH) second-quarter earnings are likely to be cushioned by its strategic divestitures as well as cost-reduction plans, partly offset by lower revenues.
Bet on These 4 Liquid Stocks for a Lucrative Portfolio
by Zacks Equity Research
Four top-ranked liquid stocks that can create a winning portfolio for investors.
Magellan Health (MGLN) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Magellan Health (MGLN) is likely to benefit from its Healthcare segment, partly offset by rise in expenses.
Molina (MOH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $135.50, marking a -0.66% move from the previous day.
Anthem's (ANTM) Q2 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Anthem's (ANTM) second-quarter earnings gain from higher revenues.
Molina (MOH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Molina (MOH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Centene's (CNC) Q2 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Centene's (CNC) second-quarter earnings benefit from higher revenues and operational efficiency.
Zacks.com featured highlights include: Amazon, Molina Healthcare, John Bean, Square and Martin Marietta
by Zacks Equity Research
Zacks.com featured highlights include: Amazon, Molina Healthcare, John Bean, Square and Martin Marietta
What to Expect for Universal Health's (UHS) Q2 Earnings
by Zacks Equity Research
Universal Health's (UHS) Q2 earnings are likely to gain from its strong segmental performances at Acute Care and Behavioral Health, partly offset by high costs.
What's in the Offing for Anthem's (ANTM) Earnings in Q2?
by Zacks Equity Research
Anthem's (ANTM) second-quarter earnings are likely to benefit from a solid revenue stream.
Ensign Group (ENSG) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 Stocks Look Primed for Solid Earnings Beat
by Sanghamitra Saha
Invest in top-ranked stocks that are likely to beat their earnings estimates in the upcoming releases.
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $142.09, marking a +1.01% move from the previous day.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Top Ranked Growth Stocks to Buy for July 17th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 17th.
Top Ranked Growth Stocks to Buy for July 16th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 16th.
Zacks.com featured highlights include: United States Cellular, Dropbox, Chipotle Mexican Grill and Molina Healthcare
by Zacks Equity Research
Zacks.com featured highlights include: United States Cellular, Dropbox, Chipotle Mexican Grill and Molina Healthcare
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $144.87, marking a +1.07% move from the previous day.
Is UnitedHealth (UNH) Stock a Buy Heading into Q2 2019 Earnings?
by Benjamin Rains
Shares of UnitedHealth Group (UNH) popped Friday after they surged Thursday to help spur the Dow Jones Industrial Average's rally. But should investors consider buying UNH stock ahead of its Q2 earnings results?
Why Molina (MOH) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 Solid Liquid Stocks to Build a Winning Portfolio
by Zacks Equity Research
Focus on four top-ranked liquid stocks that are poised to reap marvelous returns.
3 Health-Insurance Stocks to Consider When the Fed Drops Rates
by Mitchell Moore
The next Federal Reserve Open Market Committee meeting is set for July 30-31, where they will decide whether or not to cut interest rates. The market assumes a 100% probability that the Fed cuts rates by at least a quarter point, according to analysts.
Ensign Group Surges 51.8% in a Year: More Room for Upside?
by Zacks Equity Research
Ensign Group's (ENSG) inorganic growth strategies should lead to healthy revenues. This will likely bump up its share price further.